Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2023
2022
Licensing of health technologies: New Report
Research Training for the SHARP Project in DRC and Burundi
HAI welcomes new Foundation Board Chair
WTO institutionally unfit for the purpose of delivering sustainable solutions
Introducing the TRIPS Flexibilities Navigator
EU rushing WTO members to adopt weak waiver text
HAI Statement on Tentative Agreement on TRIPS and COVID-19
Marking International Women’s Day 2022
HAI is Hiring!
Call for medical journals to support clinical trial transparency
2021
Looking to 2022 with Renewed Energy
Transparency: Bringing the Issue to Life
Working with the European Parliament
WHO Recommends Malaria Vaccine for Use
Over 9 million people living with type 1 diabetes
COVID-19: European Commission gives lacklustre response to legitimate civil society concerns
Clinical Trial Data and the Risk of Bias
Getting Hack to Reality
A Pandemic Response Lacking Moral Leadership
MPs and MEPs Call for TRIPS Waiver
Challenging the IP Protection Framework
Over 100 MEPs call for a TRIPS Waiver
Access to Medicines in Europe
Health Action International at 40 – A Word from Executive Director, Tim Reed
2020